9W3

4-[(4-{4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino}-6-[3-(morpholin-4-yl)propoxy]-1,3,5-triazin-2-yl)amino]benzonitrile

Created:	2021-10-29
Last modified:	2022-03-16

Find Related PDB Entry
3 entries where 9W3 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	68
Chiral Atom Count	0
Bond Count	71
Aromatic Bond Count	18

2D diagram of 9W3

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-[(4-{4-[(E)-2-cyanoethenyl]-2,6-dimethylanilino}-6-[3-(morpholin-4-yl)propoxy]-1,3,5-triazin-2-yl)amino]benzonitrile
Systematic Name (OpenEye OEToolkits)	4-[[4-[[4-[(~{E})-2-cyanoethenyl]-2,6-dimethyl-phenyl]amino]-6-(3-morpholin-4-ylpropoxy)-1,3,5-triazin-2-yl]amino]benzenecarbonitrile
Formula	C₂₈ H₃₀ N₈ O₂
Molecular Weight	510.59
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	N#Cc1ccc(cc1)Nc1nc(nc(Nc2c(C)cc(\C=C\C#N)cc2C)n1)OCCCN1CCOCC1
SMILES	CACTVS	3.385	Cc1cc(C=CC#N)cc(C)c1Nc2nc(Nc3ccc(cc3)C#N)nc(OCCCN4CCOCC4)n2
SMILES	OpenEye OEToolkits	2.0.7	Cc1cc(cc(c1Nc2nc(nc(n2)OCCCN3CCOCC3)Nc4ccc(cc4)C#N)C)C=CC#N
Canonical SMILES	CACTVS	3.385	Cc1cc(\C=C\C#N)cc(C)c1Nc2nc(Nc3ccc(cc3)C#N)nc(OCCCN4CCOCC4)n2
Canonical SMILES	OpenEye OEToolkits	2.0.7	Cc1cc(cc(c1Nc2nc(nc(n2)OCCCN3CCOCC3)Nc4ccc(cc4)C#N)C)/C=C/C#N
InChI	InChI	1.03	InChI=1S/C28H30N8O2/c1-20-17-23(5-3-10-29)18-21(2)25(20)32-27-33-26(31-24-8-6-22(19-30)7-9-24)34-28(35-27)38-14-4-11-36-12-15-37-16-13-36/h3,5-9,17-18H,4,11-16H2,1-2H3,(H2,31,32,33,34,35)/b5-3+
InChIKey	InChI	1.03	IRRZMAXYIYCORM-HWKANZROSA-N

Related Resource References

Resource Name	Reference
PubChem	72163598
ChEMBL	CHEMBL2418594

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.